Molina Healthcare (MOH) CLO sells 17,811 shares, retains 67,175 holding

Rhea-AI Filing Summary

Molina Healthcare, Inc. Chief Legal Officer Jeff D. Barlow reported an open-market sale of 17,811 shares of common stock on May 11, 2026. The shares were sold at a volume-weighted average price of $186.12 per share, with individual trade prices ranging from $186.01 to $186.86. After this transaction, Barlow directly holds 67,175 shares of Molina Healthcare common stock. A related equity award is scheduled to vest in tranches of 7,296 shares on March 1, 2027, 6,193 shares on March 1, 2028, and 4,574 shares on March 1, 2029, with the remaining award already vested.

Insights

Insider transactions analyst

Molina’s CLO makes a sizable but partial open-market share sale.

Chief Legal Officer Jeff D. Barlow executed an open-market sale of 17,811 Molina Healthcare common shares at a volume-weighted average price of $186.12. The sale was executed across multiple trades between $186.01 and $186.86 per share.

Following the transaction, Barlow continues to hold 67,175 shares directly, indicating he retains a meaningful equity stake. The filing also outlines future vesting of additional share-based awards through 2029, which may increase his holdings as they vest, assuming no further dispositions.

The transaction is categorized as an open-market sale (code S), which is a discretionary move rather than a mechanistic tax withholding or option exercise. However, with remaining holdings and long-dated vesting, this appears as a notable but not thesis-changing liquidity event.

Insider Trade Summary

Net Seller: 17,811 shares ($3,314,983)

Net Sell 1 txn

Insider Barlow Jeff D.

Role Chief Legal Officer

Sold 17,811 shs ($3.31M)

Type	Security	Shares	Price	Value
Sale	Common Stock	17,811	$186.12	$3.31M

Holdings After Transaction: Common Stock — 67,175 shares (Direct, null)

Footnotes (1)

1. Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $186.01 to $186.86. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. The shares vest as follows: 7,296 shares on March 1, 2027; 6,193 shares on March 1, 2028; and 4,574 shares on March 1, 2029. The remaining shares are vested.

Key Figures

Shares sold: 17,811 shares Average sale price: $186.12 per share Sale price range: $186.01–$186.86 per share +4 more

7 metrics

Shares sold 17,811 shares Open-market sale on May 11, 2026

Average sale price $186.12 per share Volume-weighted average selling price

Sale price range $186.01–$186.86 per share Range of actual trade prices on transaction date

Shares held after sale 67,175 shares Direct holdings following the transaction

Future vesting 2027 7,296 shares Scheduled to vest on March 1, 2027

Future vesting 2028 6,193 shares Scheduled to vest on March 1, 2028

Future vesting 2029 4,574 shares Scheduled to vest on March 1, 2029

Key Terms

volume weighted average selling price, open-market sale, net-sell, vest

4 terms

volume weighted average selling price financial

"Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range."

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

net-sell financial

"netBuySellDirection": "net-sell""

vest financial

"The shares vest as follows: 7,296 shares on March 1, 2027; 6,193 shares on March 1, 2028; and 4,574 shares on March 1, 2029."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Barlow Jeff D.

(Last) (First) (Middle)

200 OCEANGATE, SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/11/2026		S		17,811	D	$186.12(1)	67,175(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $186.01 to $186.86. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

2. The shares vest as follows: 7,296 shares on March 1, 2027; 6,193 shares on March 1, 2028; and 4,574 shares on March 1, 2029. The remaining shares are vested.

Remarks:

	Jeff D. Barlow	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

How many Molina Healthcare (MOH) shares did Jeff Barlow sell in this Form 4?

Jeff D. Barlow sold 17,811 shares of Molina Healthcare common stock. The sale was reported as an open-market transaction at a volume-weighted average price of $186.12 per share, based on multiple trades within a narrow price range.

What price did Molina Healthcare (MOH) shares sell for in Jeff Barlow’s transaction?

The reported sale used a volume-weighted average price of $186.12 per share. Individual trades on the transaction date occurred at prices ranging from $186.01 to $186.86, according to the Form 4 footnote disclosure.

How many Molina Healthcare (MOH) shares does Jeff Barlow hold after this sale?

After the reported sale, Jeff D. Barlow directly holds 67,175 Molina Healthcare common shares. This post-transaction holding reflects his remaining direct equity stake as disclosed in the Form 4 filing’s ownership information.

What type of insider transaction did Molina Healthcare (MOH) report for Jeff Barlow?

The filing shows an open-market sale of common stock, coded “S” on Form 4. This indicates Barlow sold shares in the market rather than exercising options, receiving a grant, or disposing shares for tax withholding purposes.

Does the Form 4 show future vesting of Molina Healthcare (MOH) shares for Jeff Barlow?

Yes. A disclosed award vests in tranches of 7,296 shares on March 1, 2027, 6,193 shares on March 1, 2028, and 4,574 shares on March 1, 2029. The filing notes that the remaining shares under that award are already vested.

Is Jeff Barlow’s Molina Healthcare (MOH) sale characterized as a net buy or net sell?

The transaction summary reflects a net-sell position for this Form 4. It reports one sale transaction totaling 17,811 shares sold, with no corresponding purchases, exercises, gifts, or tax-withholding entries during the reported period.